Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

Memorial Sloan Kettering Cancer Center-led researchers have identified a small molecule called gliocidin that kills ...

Fox News contributor and medical expert Dr. Kelly Powers has died following a battle with glioblastoma brain cancer. She was ...

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics ...

Dr. Kelly Powers, a Fox News commentator, has died. She was 45. The physician and surgeon died on Sunday, December 1, after ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the ...

As the first cohort of patients are dosed as part of the first stage of the Phase II trial, the company has announced the ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, ...

Used in conjunction with the oral sonosensitizing agent 5-ALA, the sonodynamic therapy led to a median OS of 15.7 months in ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies ...